Patents by Inventor Sei-Won Laura Chang

Sei-Won Laura Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF GENOMIC SIGNATURES TO PREDICT RESPONSIVENESS OF PATIENTS WITH PROSTATE CANCER TO POST-OPERATIVE RADIATION THERAPY
    Publication number: 20230151429
    Abstract: Methods, compositions, and kits for identifying individuals who will be responsive to post-operative radiation therapy for treatment of prostate cancer are disclosed. In particular, the invention relates to a genomic signature based on expression levels of DNA Damage Repair genes that can be used to identify individuals likely to benefit from post-operative radiation therapy after a prostatectomy.
    Type: Application
    Filed: August 15, 2022
    Publication date: May 18, 2023
    Inventors: Elai Davicioni, Hussam Al-Deen Ashab, Nicholas Erho, Shuang G. Zhao, Sei-Won Laura Chang, Felix Y. Feng
  • Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
    Patent number: 11414708
    Abstract: Methods, compositions, and kits for identifying individuals who will be responsive to post-operative radiation therapy for treatment of prostate cancer are disclosed. In particular, the invention relates to a genomic signature based on expression levels of DNA Damage Repair genes that can be used to identify individuals likely to benefit from post-operative radiation therapy after a prostatectomy.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: August 16, 2022
    Assignee: Decipher Biosciences, Inc.
    Inventors: Elai Davicioni, Hussam Al-Deen Ashab, Nicholas Erho, Shuang G. Zhao, Sei-Won Laura Chang, Felix Y. Feng